SPUR THERAPEUTICS
Spur Therapeutics is a clinical-stage biotechnology business dedicated to creating life-changing medicines for crippling chronic illnesses.
SPUR THERAPEUTICS
Industry:
Biotechnology Health Care Medical
Founded:
2024-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.spurtherapeutics.com
Total Employee:
101+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
50 M USD
Current Advisors List
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-06-17 | Freeline | Freeline acquired by Spur Therapeutics | N/A |
| 2024-06-17 | SwanBio Therapeutics | SwanBio Therapeutics acquired by Spur Therapeutics | N/A |
Investors List
Syncona Partners LLP
Syncona Partners LLP investment in Private Equity Round - Spur Therapeutics
Official Site Inspections
http://www.spurtherapeutics.com
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Spur Therapeutics"
Our Company | Spur Therapeutics
Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing gene therapies for debilitating chronic conditions.See details»
Our Leadership - Spur Therapeutics
Henning has more than 25 years of experience in scientific research and leadership. Prior to joining Spur Therapeutics in March 2022, he held …See details»
Spur Therapeutics - LinkedIn
Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By …See details»
Spur Therapeutics - Crunchbase Company Profile
Organization. Spur Therapeutics . Connect to CRM . Save . Summary. …See details»
Spur Therapeutics - Our spinouts - Portfolio - UCLB
UCL Business Ltd (UCLB), is a wholly owned subsidiary of UCL (University College London). Working with UCL’s world-renowned academics, faculties and associated hospitals, UCLB …See details»
Spur Therapeutics (Formerly Freeline) Announces New Name and …
Jun 17, 2024 “At Spur Therapeutics, our mission is to redefine what gene therapy can do,” said Michael Parini, Spur’s Chief Executive Officer. “Our new name and new brand reflect our …See details»
Spur Therapeutics (Formerly Freeline) Announces New Name
Jun 17, 2024 [email protected] + 1 617 283 4298. A video accompanying this announcement is available at ...See details»
Spur Therapeutics Ltd. - Drug pipelines, Patents, Clinical trials
Explore Spur Therapeutics Ltd. with its drug pipeline, therapeutic area, technology platform, 5 clinical trials, 14 news, and 3 literature, Disease Domain:Nervous System Diseases, …See details»
Contact | Spur Therapeutics
Company or organization (if applicable) Email * Phone number * What is this about? Your message * Email. This field is for validation purposes and should be left unchanged. Submit. …See details»
Spur Therapeutics’ Post - LinkedIn
At Spur, we are principled – our team does what’s right, not what’s easy. We lead with a deep sense of responsibility to each other, and to the patient communities we aim to serve by ...See details»
Spur Therapeutics | Clinical companies | Portfolio - Syncona
Investment thesis. Spur has two potential first-in-class gene therapy programmes. Its lead programme is a highly differentiated gene therapy candidate, FLT201, for Gaucher disease …See details»
Spur Therapeutics Holdings Ltd. (Spur Therapeutics Holdings Ltd.)
Toward life-changing therapies, and brighter futures. Toward More™ For more information, visit www.spurtherapeutics.com or connect with Spur on LinkedIn and X. Investor ContactNaomi …See details»
News & Data | Spur Therapeutics
May 15, 2025 Spur Therapeutics is constantly advancing the practice of genetic medicine. Explore our latest results, updates, events, publications, and more.See details»
Spur Therapeutics’ Post - LinkedIn
At Spur, we are bold – as we work to expand the potential of gene therapy, our team fearlessly embraces uncharted territory in order to move the standard of…See details»
Spur Therapeutics Presents Positive New Clinical and
May 15, 2025 [email protected] + 1 617 780 2182 1 Transient anti-GCase antibodies were also observed in a second participant with low transduction efficiency who …See details»
Spur Therapeutics - Overview, News & Similar companies
Jul 8, 2024 Who is Spur Therapeutics. Based in Stevenage, England, Spur Therapeutics is a clinical-stage biotechnology company focused on developing life-changing therapies for …See details»
Spur Therapeutics Publishes Preclinical Proof-of-Concept
10 hours ago [email protected] + 1 617 283 4298. Media Contact Carolyn Noyes [email protected] + 1 617 780 2182. Recommended Reading. May …See details»
Our Programs | Spur Therapeutics
Gaucher Disease . Even with current treatments, many people with Gaucher disease still experience debilitating symptoms. Our gene therapy candidate, FLT201, uses our GCase85 …See details»
Exciting announcement: Freeline is now Spur Therapeutics
Exciting announcement: Freeline is now Spur Therapeutics! Our new name and branding reflects our dedication to advancing the practice of genetic medicine, moving toward a new generation …See details»
Spur Therapeutics Publishes Preclinical Proof-of-Concept Data for ...
22 hours ago [email protected] + 1 617 283 4298. Media Contact Carolyn Noyes [email protected] + 1 617 780 2182.See details»